$2.13
0.0653.16%
At close: Jul 10, 5:00 PM EST
$2.12
-0.005-0.24%
After Hours: 7:52 PM EST
ALX Oncology Holdings Inc Earnings Estimates
ALXONASDAQ
ALX Oncology Holdings Earnings Estimates, EPS & Revenue | NASDAQ:ALXO
ALX Oncology Holdings (ALXO) is scheduled to report Q2 earnings on August 11, 2026. Analysts estimate EPS of $-0.15 and quarterly revenue of N/A.
In the most recent quarter (Q1), ALX Oncology Holdings reported EPS of $-0.15, beating estimates of $-0.16 by 0.08%. Revenue came in at $0, meeting the estimate of $0 by 0.00%.
Over the last 4 quarters, ALX Oncology Holdings has averaged an EPS surprise of 0.10% and a revenue surprise of 0.00%.
Earnings Date
Aug 11
EPS Estimate
$-0.150
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
ALX Oncology Holdings Earnings History
Analyze the earnings history of ALX Oncology Holdings using advanced sorting and filters.
Loading calendar...
ALX Oncology Holdings (ALXO) Earnings Per Share
The chart below shows ALX Oncology Holdings's reported EPS compared to analyst estimates over recent quarters.
ALX Oncology Holdings (ALXO) Revenue
The chart below shows ALX Oncology Holdings's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is ALX Oncology Holdings (NASDAQ:ALXO) reporting earnings?
ALX Oncology Holdings (ALXO) is scheduled to report earnings on August 11, 2026. The last reported earnings were for reported on May 8, 2026 for Q1.
What were the latest earnings per share (EPS) for ALX Oncology Holdings (NASDAQ:ALXO)?
The Actual EPS was $-0.15, which beat the estimate of $-0.16.
What were ALX Oncology Holdings’s (NASDAQ:ALXO) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
